NASDAQ:BLUE - bluebird bio Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$103.00 -1.57 (-1.50 %)
(As of 12/18/2018 12:54 PM ET)
Previous Close$104.57
Today's Range$101.00 - $105.62
52-Week Range$99.15 - $236.17
Volume514,728 shs
Average Volume730,873 shs
Market Capitalization$5.65 billion
P/E Ratio-13.36
Dividend YieldN/A
Beta2.37

Analyst Ratings

bluebird bio (NASDAQ:BLUE) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
22 Wall Street analysts have issued ratings and price targets for bluebird bio in the last 12 months. Their average twelve-month price target is $193.6250, suggesting that the stock has a possible upside of 87.99%. The high price target for BLUE is $250.00 and the low price target for BLUE is $120.00. There are currently 1 sell rating, 8 hold ratings and 13 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyHoldBuy
Consensus Rating Score: 2.552.602.482.57
Ratings Breakdown: 1 Sell Rating(s)
8 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
8 Hold Rating(s)
16 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
9 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
8 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $193.6250$206.7895$212.05$213.4737
Price Target Upside: 87.99% upside71.92% upside54.56% upside20.85% upside

bluebird bio (NASDAQ:BLUE) Consensus Price Target History

Price Target History for bluebird bio (NASDAQ:BLUE)

bluebird bio (NASDAQ:BLUE) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/9/2018CowenReiterated RatingBuyLowView Rating Details
12/6/2018Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$240.00 ➝ $120.00MediumView Rating Details
12/4/2018OppenheimerReiterated RatingHoldLowView Rating Details
12/4/2018William BlairReiterated RatingBuyLowView Rating Details
12/3/2018Janney Montgomery ScottSet Price TargetOutperform ➝ Buy$170.00HighView Rating Details
12/3/2018Maxim GroupReiterated RatingHoldHighView Rating Details
12/3/2018Cantor FitzgeraldReiterated RatingHold$134.00HighView Rating Details
11/27/2018Leerink SwannInitiated CoverageOutperform$145.00 ➝ $145.00LowView Rating Details
11/14/2018Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$155.00HighView Rating Details
11/5/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$186.00 ➝ $185.00LowView Rating Details
11/5/2018WedbushLower Price TargetOutperform ➝ Outperform$204.00 ➝ $166.00MediumView Rating Details
9/21/2018Goldman Sachs GroupDowngradeConviction-Buy ➝ BuyMediumView Rating Details
9/17/2018GuggenheimInitiated CoverageNeutralMediumView Rating Details
8/3/2018SunTrust BanksReiterated RatingBuy$223.00HighView Rating Details
8/3/2018BMO Capital MarketsReiterated RatingBuy$208.00HighView Rating Details
7/12/2018GabelliInitiated CoverageBuy$239.00LowView Rating Details
6/19/2018Evercore ISIUpgradeIn-Line ➝ Outperform$175.00 ➝ $230.00LowView Rating Details
5/3/2018BTIG ResearchReiterated RatingBuyHighView Rating Details
3/28/2018Canaccord GenuityReiterated RatingBuyLowView Rating Details
3/16/2018UBS GroupInitiated CoverageSellHighView Rating Details
2/22/2018Bank of AmericaBoost Price TargetNeutral ➝ Neutral$185.00 ➝ $218.00MediumView Rating Details
12/21/2017CIBCInitiated CoverageMarket Perform ➝ Market PerformHighView Rating Details
12/13/2017BarclaysReiterated RatingOverweight ➝ Overweight$162.00 ➝ $209.00HighView Rating Details
12/12/2017Wells Fargo & CoReiterated RatingOutperform$190.00 ➝ $242.00HighView Rating Details
12/11/2017Jefferies Financial GroupUpgradeHold ➝ Buy$130.00 ➝ $211.00HighView Rating Details
6/16/2017Standpoint ResearchReiterated RatingBuy ➝ Reduce$110.00LowView Rating Details
2/23/2017Roth CapitalSet Price TargetHold$71.00N/AView Rating Details
(Data available from 12/18/2016 forward)
This page was last updated on 12/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel